Prévisions du marché des organisations de vente sous contrat pharmaceutique au Moyen-Orient et en Afrique jusqu\'en 2030 – Analyse régionale – par services (services commerciaux et services non commerciaux), modules (modules syndiqués et modules dédiés), domaine thérapeutique (troubles cardiovasculaires, oncologie, troubles métaboliques, neurologie, Maladies orthopédiques, maladies infectieuses et autres) et utilisateur final (sociétés biopharmaceutiques et sociétés pharmaceutiques)
Expansion en Les marchés émergents alimentent le marché des organisations de vente sous contrat pharmaceutique au Moyen-Orient et en Afrique. La trajectoire future du marché des organisations de vente sous contrat pharmaceutique (CSO) est clairement façonnée par la tendance stratégique d\'expansion sur les marchés émergents. À mesure que le paysage pharmaceutique mondial s’agrandit et que les économies émergentes gagnent en importance, les OSC reconnaissent de plus en plus le potentiel inexploité. Les marchés émergents présentent des opportunités liées à une sensibilisation croissante aux soins de santé, à l’expansion de la classe moyenne et à l’augmentation des investissements gouvernementaux dans les infrastructures de santé. En étendant leurs opérations sur ces marchés en plein essor, les OSC peuvent capitaliser sur la demande croissante de produits pharmaceutiques et s’implanter rapidement sur des marchés prêts à connaître une croissance substantielle. Cependant, cette expansion nécessite une compréhension judicieuse des paysages réglementaires locaux, des nuances culturelles et de la diversité des systèmes de santé. Une expansion réussie sur les marchés émergents nécessite une approche sur mesure, dans laquelle les OSC doivent aligner leurs stratégies sur les défis et opportunités uniques de chaque région. En outre, de telles expansions positionnent les OSC comme des acteurs cruciaux dans l’écosystème mondial des soins de santé, contribuant à la croissance des revenus et à l’objectif plus large d’améliorer l’accessibilité et les résultats des soins de santé sur ces marchés en évolution. Essentiellement, l’évolution stratégique vers l’expansion sur les marchés émergents apparaît comme une tendance tournée vers l’avenir, reflétant la capacité d’adaptation et la clairvoyance des OSC pharmaceutiques face aux complexités d’un paysage pharmaceutique mondialisé. Aperçu du marché des organisations de vente sous contrat pharmaceutique au Moyen-Orient et en Afrique. Le marché des organisations de vente sous contrat pharmaceutique au Moyen-Orient et en Afrique est segmenté en Arabie saoudite, en Afrique du Sud, aux Émirats arabes unis et dans le reste de la MEA. Les facteurs à l’origine de la croissance du marché comprennent l’intégration croissante des technologies numériques et l’intérêt croissant des sociétés pharmaceutiques pour augmenter les ventes de produits. Cependant, les problèmes de qualité associés à l’externalisation freinent la croissance du marché. Les Émirats arabes unis sont un pays développé de la région et leur secteur de la santé a connu une croissance remarquable, principalement en raison de l\'augmentation de la population et d\'une recrudescence de la demande de produits pharmaceutiques. Le secteur progressiste de la santé offre des opportunités de croissance vitales à l’industrie pharmaceutique. Les Émirats arabes unis possèdent l’une des industries pharmaceutiques à la croissance la plus rapide au monde, également connue pour son adoption des technologies de pointe. Des initiatives telles que la Stratégie industrielle de Dubaï 2030 et la Vision d\'Abu Dhabi 2030 se concentrent sur le développement du secteur pharmaceutique national en tenant compte des perspectives de croissance future, du potentiel d\'exportation et de l\'impact économique à moyen et long terme. Les progrès significatifs de la recherche scientifique favorisent le développement et la production de médicaments au potentiel innovant. La concurrence féroce dans l’industrie pharmaceutique oblige les entreprises à commercialiser leurs produits thérapeutiques le plus rapidement possible pour rester au sommet du marché. Ainsi, la demande croissante de produits pharmaceutiques efficaces, le nombre croissant de sociétés pharmaceutiques, l\'incidence croissante des maladies infectieuses et chroniques et les lancements fréquents de produits soutiennent les progrès de l\'industrie pharmaceutique au Moyen-Orient et en Afrique, nécessitant ainsi le recours aux services des OSC. ce qui favorise la croissance du marché des organisations de vente sous contrat pharmaceutique dans la région.
Chiffre d\'affaires et prévisions du marché des organisations de vente sous contrat pharmaceutique au Moyen-Orient et en Afrique jusqu\'en 2030 (en millions de dollars américains)
Segmentation du marché des organisations de vente sous contrat pharmaceutique au Moyen-Orient et en Afrique
Le marché des organisations de vente sous contrat pharmaceutique au Moyen-Orient et en Afrique est segmenté en services, modules, domaine thérapeutique, utilisateur final et pays.
Basé sur les services, le marché des organisations de vente sous contrat pharmaceutique au Moyen-Orient et en Afrique est divisé en services commerciaux et services non commerciaux. Le segment des services commerciaux détenait une part plus importante du marché des organisations de vente sous contrat pharmaceutique au Moyen-Orient et en Afrique en 2022.
Sur la base de modules, le marché des organisations de vente sous contrat pharmaceutique au Moyen-Orient et en Afrique est divisé en modules syndiqués et modules dédiés. Le segment des modules syndiqués détenait une part plus importante du marché des organisations de vente sous contrat pharmaceutique au Moyen-Orient et en Afrique en 2022.
Sur la base du domaine thérapeutique, le marché des organisations de vente sous contrat pharmaceutique au Moyen-Orient et en Afrique est segmenté en troubles cardiovasculaires, oncologie et troubles métaboliques. , neurologie, maladies orthopédiques, maladies infectieuses et autres. Le segment de l\'oncologie détenait la plus grande part du marché des organisations de vente sous contrat pharmaceutique au Moyen-Orient et en Afrique en 2022.
Sur la base de l\'utilisateur final, le marché des organisations de vente sous contrat pharmaceutique au Moyen-Orient et en Afrique est divisé en sociétés biopharmaceutiques et sociétés pharmaceutiques. Le segment des sociétés pharmaceutiques détenait une part plus importante du marché des organisations de vente sous contrat pharmaceutique au Moyen-Orient et en Afrique en 2022.
En fonction du pays, le marché des organisations de vente sous contrat pharmaceutique au Moyen-Orient et en Afrique est segmenté en Arabie Saoudite, Afrique du Sud et Émirats arabes unis. , et le reste du Moyen-Orient et de l\'Afrique. L\'Arabie Saoudite a dominé le marché des organisations de vente sous contrat pharmaceutique au Moyen-Orient et en Afrique en 2022.
Aenova Holding GmbH, IQVIA Holdings Inc, Pfizer Inc et Syneos Health Inc sont quelques-unes des principales sociétés opérant dans la vente sous contrat pharmaceutique au Moyen-Orient et en Afrique. marché des organisations.
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East & Africa PEST Analysis
5. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Integration of Digital Technologies
5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products
5.2 Key Market Restraints
5.2.1 Quality Issues Associated with Outsourcing
5.3 Key Market Opportunities
5.3.1 Rising Use of Telemedicine and Remote Detailing
5.4 Key Future Trends
5.4.1 Expansion in Emerging Markets
5.5 Impact Analysis:
6. Pharmaceutical Contract Sales Organizations Market - Middle East & Africa Analysis
6.1 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030
7. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Services
7.1 Overview
7.2 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
7.3 Commercial Services
7.3.1 Overview
7.3.2 Commercial Services: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Non-Commercial Services
7.4.1 Overview
7.4.2 Non-Commercial Services: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Modules
8.1 Overview
8.2 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
8.3 Syndicated Modules
8.3.1 Overview
8.3.2 Syndicated Modules: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Dedicated Modules
8.4.1 Overview
8.4.2 Dedicated Modules: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Therapeutic Area
9.1 Overview
9.2 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
9.3 Cardiovascular Disorders
9.3.1 Overview
9.3.2 Cardiovascular Disorders: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Oncology
9.4.1 Overview
9.4.2 Oncology: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Metabolic Disorders
9.5.1 Overview
9.5.2 Metabolic Disorders: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Neurology
9.6.1 Overview
9.6.2 Neurology: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.7 Orthopaedic Diseases
9.7.1 Overview
9.7.2 Orthopedic Diseases: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.8 Infectious Diseases
9.8.1 Overview
9.8.2 Infectious Diseases: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.9 Others
9.9.1 Overview
9.9.2 Others: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by End User
10.1 Overview
10.2 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
10.3 Biopharmaceutical Companies
10.3.1 Overview
10.3.2 Biopharmaceutical Companies: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Pharmaceutical Companies
10.4.1 Overview
10.4.2 Pharmaceutical Companies: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
11. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Country Analysis
11.1 Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Country
11.1.1 Saudi Arabia
11.1.1.1 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.2 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.3 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.4 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.5 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.2 UAE
11.1.2.1 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.2 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.2.3 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.2.4 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.2.5 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.3 South Africa
11.1.3.1 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.3.2 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.3.3 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.3.4 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.3.5 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.4 Rest of Middle East & Africa
11.1.4.1 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.4.2 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.4.3 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.4.4 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.4.5 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
12. Pharmaceutical Contract Sales Organizations Market - Industry Landscape
12.1 Overview
12.2 Growth Strategies
12.2.1 Overview
13. Company Profiles
13.1 IQVIA Holdings Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Syneos Health Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Aenova Holding GmbH
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Pfizer Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms
?
List of Tables
Table 1. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Segmentation
Table 2. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 3. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 4. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 5. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 6. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 7. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 8. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 9. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 10. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 11. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 12. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 13. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 15. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 16. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 17. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market
Table 19. Glossary of Terms, Middle East & Africa Pharmaceutical Contract Sales Organizations Market
?
List of Figures
Figure 1. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Segmentation, By Country
Figure 2. Middle East & Africa - PEST Analysis
Figure 3. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030
Figure 6. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
Figure 7. Commercial Services: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Non-Commercial Services: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
Figure 10. Syndicated Modules: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Dedicated Modules: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
Figure 13. Cardiovascular Disorders: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Oncology: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Metabolic Disorders: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Neurology: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Orthopedic Diseases: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Infectious Diseases: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 21. Biopharmaceutical Companies: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Pharmaceutical Companies: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 24. Middle East & Africa Pharmaceutical Contract Sales Organizations Market, By Key Countries, 2022 and 2030 (%)
Figure 25. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
1. Aenova Holding GmbH
2. IQVIA Holdings Inc
3. Pfizer Inc
4. Syneos Health Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa Pharmaceutical Contract Sales Organizations Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa Pharmaceutical Contract Sales Organizations Market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.